Call (844) 879-2237

Author Archives: Wenqi Yue

Acera Surgical Awarded Federal Supply Schedule (FSS) Contract for Restrata® Wound Matrix

St. Louis, MO, August 8, 2018 – Acera Surgical, a leader in implantable nanomedical scaffolds, announced today that the National Acquisition Center of the Department of Veterans Affairs has awarded the company a Federal Supply Schedule (FSS) contract, effective August […]

Read More

Dr. Matthew Regulski to Present Clinical Results of RestrataⓇ Wound Matrix at  International Wound Care Conference

St. Louis, Missouri, June 12, 2018 – Dr. Matthew Regulski, DPM, will be giving a presentation titled “Clinical Evaluation of a Novel Nanofiber Matrix For the Treatment of Chronic Wounds” at the International Conference on Wound Care, Tissue Repair & […]

Read More

Cerafix® Leakage Test Video

Acera has created a new leakage test video. The video compared Cerafix® with another commercially-available product (DuraGen Plus®) within a 2-minute timeframe. The video can be found on YouTube and on our company website (www.acera-surgical.com). Read More

Acera Surgical Sponsors Saint Louis University Wound Healing Symposium

St. Louis, MO, May 16, 2018 – Acera Surgical, a leader in implantable nanomedical scaffolds, is pleased to announce its support as the sponsor of the third annual Saint Louis University Wound Healing Symposium, to be held on May 24th […]

Read More

New Research Highlights Restrata® Wound Matrix Results

Acera Surgical Announces Positive Results from Clinical Study Examining The Use of Restrata® Wound Matrix In Healing Chronic Lower Extremity Wounds
St. Louis, MO—April 18, 2018— Acera Surgical Inc., the industry leader in implantable nanomedical scaffolds, has been selected to present […]

Read More
Post Image

Acera’s SAWC 2017 Poster

Read More

Acera Surgical Publishes Manuscript Highlighting the Mechanism of Action of Nanofabricated Restrata™ Wound Matrix

St. Louis, MO— October 5th, 2017— Acera Surgical Inc., a bioscience company dedicated to the commercialization of fully synthetic electrospun scaffolds for medical applications, announced today the publication of scientific manuscript describing the mechanism of action of the Restrata™ Wound […]

Read More

Acera to Start Clinical Trial on Restrata™ Wound Matrix

St. Louis, MO. September 15, 2017- Acera is starting a clinical trial on Restrata™ Wound Matrix with a focus on diabetic foot ulcer.  Acera will be working with Telos Partner to manage the clinical trial. The study is titled: “Clinical Outcomes […]

Read More

Acera Surgical Announces Publication of Pre-Clinical Study on Restrata™

St. Louis, MO—September 5, 2017— Acera Surgical Inc., a company dedicated to the development and commercialization of fully synthetic electrospun scaffolds for medical applications, announced today the publication of results from the pre-clinical study of the efficacy of Restrata Wound […]

Read More

Acera Surgical to Present Results of Study on the Use of Restrata™ Wound Matrix in Healing Full-thickness Wounds at Fall Symposium on Advanced Wound Care

St. Louis, MO—August 29, 2017— Acera Surgical Inc. has been selected to present the results from a study involving the Restrata™ Wound Matrix at the Fall 2017 Symposium on Advanced Wound Care (“SAWC”), being held in Las Vegas, Nevada, from October […]

Read More